Findings

What do systematic reviews say?

3,006 questions · 3,171 findings · 607 reviews · Headline outcomes only

Sort:Best matchNewest Highest certainty Download CSV

No studies found 411 · 13%GRADE not reported 153 · 4.8%Very low 968 · 30.5%Low 897 · 28.3%Moderate 589 · 18.6%High 153 · 4.8%

Interventions for involving older patients with multi‐morbidity in decision‐making about their health care vs usual care

Health status (a) Patient‐reported high self‐rated health at 6 months after baseline CDC Healthy Days Measure (CDC 2000): dichotomised as low (1 to 3) and high (4 to 5) · older patients with multi‐morbidity

It is very uncertain whether interventions for involving older patients with multi‐morbidity in… changes health status (a) Patient‐reported high self‐rated health at 6… compared with usual care (very low certainty).

1 finding from 1 review

Interventions for involving older patients with multi‐morbidity in decision‐making during primary care consultations 2019 · Cochrane Headline outcomes only
RR 1.4 [0.36, 5.49]
1 study · 41 participants
Very low

Animal‐assisted therapy (AAT (live animal)) vs no AAT

Depressive symptoms · people with dementia

1 finding from 1 review

Animal‐assisted therapy for dementia 2019 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 83 participants
Low

Animal‐assisted therapy (AAT (live animal)) vs robotic animals

Neuropsychiatric symptoms · people with dementia

1 finding from 1 review

Animal‐assisted therapy for dementia 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 78 participants
Low

Animal‐assisted therapy (AAT (live animal)) vs robotic animals

Health‐related quality of life measured using QUALID (12–45, higher score indicates poorer quality of life) · people with dementia

1 finding from 1 review

Animal‐assisted therapy for dementia 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 78 participants
Low

Animal‐assisted therapy (AAT (live animal)) vs no AAT

Social functioning measured using MOSES, Withdrawn Behaviour subscale (8‐ 32, higher score indicates more severe withdrawn behaviour) · people with dementia

1 finding from 1 review

Animal‐assisted therapy for dementia 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 58 participants
Low

Animal‐assisted therapy (AAT (live animal)) vs no AAT

Behaviour · people with dementia

1 finding from 1 review

Animal‐assisted therapy for dementia 2019 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 142 participants
Very low

Animal‐assisted therapy (AAT (live animal)) vs no AAT

Agitation and irritability · people with dementia

1 finding from 1 review

Animal‐assisted therapy for dementia 2019 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 143 participants
Very low

Animal‐assisted therapy (AAT (live animal)) vs no AAT

Health‐related quality of life measured using QUALID (12–45, higher score indicates poorer quality of life) · people with dementia

1 finding from 1 review

Animal‐assisted therapy for dementia 2019 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 164 participants
Moderate

Animal‐assisted therapy (AAT (live animal)) vs no AAT

ADL outcome · people with dementia

1 finding from 1 review

Animal‐assisted therapy for dementia 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 37 participants
Low

Animal‐assisted therapy (AAT (live animal)) vs no AAT

Physical functioning: self‐care ability measured using MOSES Self‐Care Functioning subscale (8–32, higher score indicates poorer function) · people with dementia

1 finding from 1 review

Animal‐assisted therapy for dementia 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 58 participants
Low

Intervention not reported

RVX (high dose, 10 mg to 20 mg) vs VKA · adults who underwent percutaneous coronary intervention and who have an indication for anticoagulation

1 finding from 1 review

Non‐vitamin K antagonist oral anticoagulants (NOACs) post‐percutaneous coronary intervention: a network meta‐analysis 2019 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 1546 participants
Very low

Intervention not reported

DAB (high dose, 150 mg) vs VKA · adults who underwent percutaneous coronary intervention and who have an indication for anticoagulation

1 finding from 1 review

Non‐vitamin K antagonist oral anticoagulants (NOACs) post‐percutaneous coronary intervention: a network meta‐analysis 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 1527 participants
Low

Intervention not reported

RVX (high dose, 10 mg to 20 mg) vs VKA · adults who underwent percutaneous coronary intervention and who have an indication for anticoagulation

1 finding from 1 review

Non‐vitamin K antagonist oral anticoagulants (NOACs) post‐percutaneous coronary intervention: a network meta‐analysis 2019 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 1546 participants
Very low

Intervention not reported

DAB (high dose, 150 mg) vs VKA · adults who underwent percutaneous coronary intervention and who have an indication for anticoagulation

1 finding from 1 review

Non‐vitamin K antagonist oral anticoagulants (NOACs) post‐percutaneous coronary intervention: a network meta‐analysis 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 1527 participants
Low

Intervention not reported

RVX (high dose, 10 mg to 20 mg) vs VKA · adults who underwent percutaneous coronary intervention and who have an indication for anticoagulation

1 finding from 1 review

Non‐vitamin K antagonist oral anticoagulants (NOACs) post‐percutaneous coronary intervention: a network meta‐analysis 2019 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 1542 participants
Very low

Intervention not reported

RVX (high dose, 10 mg to 20 mg) vs VKA · adults who underwent percutaneous coronary intervention and who have an indication for anticoagulation

1 finding from 1 review

Non‐vitamin K antagonist oral anticoagulants (NOACs) post‐percutaneous coronary intervention: a network meta‐analysis 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 1393 participants
Low

Intervention not reported

DAB (high dose, 150 mg) vs VKA · adults who underwent percutaneous coronary intervention and who have an indication for anticoagulation

1 finding from 1 review

Non‐vitamin K antagonist oral anticoagulants (NOACs) post‐percutaneous coronary intervention: a network meta‐analysis 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 1527 participants
Low

Intervention not reported

RVX (high dose, 10 mg to 20 mg) vs VKA · adults who underwent percutaneous coronary intervention and who have an indication for anticoagulation

1 finding from 1 review

Non‐vitamin K antagonist oral anticoagulants (NOACs) post‐percutaneous coronary intervention: a network meta‐analysis 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 1389 participants
Low

Intervention not reported

DAB (high dose, 150 mg) vs VKA · adults who underwent percutaneous coronary intervention and who have an indication for anticoagulation

1 finding from 1 review

Non‐vitamin K antagonist oral anticoagulants (NOACs) post‐percutaneous coronary intervention: a network meta‐analysis 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 1527 participants
Low

Intervention not reported

RVX (high dose, 10 mg to 20 mg) vs VKA · adults who underwent percutaneous coronary intervention and who have an indication for anticoagulation

1 finding from 1 review

Non‐vitamin K antagonist oral anticoagulants (NOACs) post‐percutaneous coronary intervention: a network meta‐analysis 2019 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 1542 participants
Very low